Adjuvant chemotherapy in stage III colon carcinoma in patients age or 70 years. Feasibility of CAPOX scheme oxaliplatin 70 mg/mq days 1-8 and capecitabine 1000 mg/mq X 2 die days 1-14 every 21 days for 6 cycles.
Phase of Trial: Phase II
Latest Information Update: 31 May 2011
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Colon cancer
- Focus Adverse reactions; Therapeutic Use
- 31 May 2011 New trial record